Public-private partnerships in the pharmaceutical sector are vital for accelerating job creation and infrastructure development in SA, says malaria researcher Kelly Chibale. A quarter of South Africans are unemployed, while the country continues to outsource pharmaceutical manufacturing to countries such as India. The state-owned pharmaceutical firm Ketlaphela is yet to begin production of medicines. Chibale said collaborative research and development between universities, industry and the government created jobs and infrastructure for economic growth and attracted foreign direct investment. His state-of-the-art Drug Discovery and Development Centre at the University of Cape Town has developed groundbreaking single-dose drugs that could cure malaria, a disease that kills more than 1,200 people a day. In 2014‚ MMV048 became the first new antimalaria medicine to enter human studies in Africa. Chibale started his research with a staff of five postdoctoral graduates that has now multipl...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.